4//SEC Filing
Huang Dennis Karl 4
Accession 0001209191-21-031390
CIK 0001515673other
Filed
May 9, 8:00 PM ET
Accepted
May 10, 6:14 PM ET
Size
5.1 KB
Accession
0001209191-21-031390
Insider Transaction Report
Form 4
Huang Dennis Karl
See Remarks
Transactions
- Sale
Common Stock
2021-05-06$113.68/sh−363$41,266→ 40,506 total
Footnotes (3)
- [F1]Represents shares sold to pay required tax withholdings due to the vesting of RSUs.
- [F2]Includes 108 shares acquired under the Company's 2014 Employee Stock Purchase Plan on April 30, 2021.
- [F3]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Documents
Issuer
Ultragenyx Pharmaceutical Inc.
CIK 0001515673
Entity typeother
Related Parties
1- filerCIK 0001641217
Filing Metadata
- Form type
- 4
- Filed
- May 9, 8:00 PM ET
- Accepted
- May 10, 6:14 PM ET
- Size
- 5.1 KB